304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial
Autor: | F-C Bidard, Anne Pradines, Suzette Delaloge, Delphine Loirat, Valérie Delecroix, S. Nguyen, M-A Mouret-Reynier, Thomas Bachelot, C. Greilsamer, J-S. Frenel, Jérôme Lemonnier, C. Levy, A-C. Hardy-Bessard, T. de La Motte Rouge, Florence Dalenc, N. Bonichon-Lamichhane, Frédérique Berger, Barbara Pistilli, Sibille Everhard, Céline Callens |
---|---|
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Annals of Oncology. 31:S364 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |